Vertex Pharmaceuticals Inc / Ma

Skandinaviska Enskilda Banken AB (publ) VRTX

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

174,466

Value ($000)

79,096

Weight

0.3%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	79,096	0.3%	174,466	12/31/2025
2025 Q3	11/7/2025	60,393	0.2%	154,248	9/30/2025
2025 Q2	8/13/2025	78,647	0.3%	176,604	6/30/2025
2025 Q1	5/7/2025	90,356	0.4%	186,471	3/31/2025
2024 Q4	2/10/2025	68,302	0.3%	171,034	12/31/2024
2024 Q3	11/7/2024	86,195	0.4%	185,285	9/30/2024
2024 Q2	8/13/2024	102,506	0.5%	218,833	6/30/2024
2024 Q1	5/13/2024	110,820	0.5%	264,923	3/31/2024
2023 Q4	2/14/2024	99,261	0.6%	243,738	12/31/2023
2023 Q3	11/9/2023	113,628	0.7%	326,630	9/30/2023
2023 Q2	8/7/2023	132,651	0.9%	376,946	6/30/2023
2023 Q1	5/11/2023	139,892	1.0%	444,003	3/31/2023
2022 Q4	2/8/2023	117,399	0.9%	406,534	12/31/2022
2022 Q3	11/14/2022	101,834	0.8%	351,711	9/30/2022
2022 Q2	8/10/2022	71,364	0.5%	253,253	6/30/2022
2022 Q1	5/11/2022	60,553	0.4%	232,032	3/31/2022
2021 Q4	2/10/2022	64,049	0.3%	287,924	12/31/2021
2021 Q3	11/10/2021	54,069	0.3%	298,085	9/30/2021
2021 Q2	8/10/2021	61,813	0.4%	306,563	6/30/2021
2021 Q1	5/14/2021	74,181	0.5%	345,207	3/31/2021
2020 Q4	2/11/2021	62,950	0.4%	266,353	12/31/2020
2020 Q3	11/12/2020	73,113	0.5%	268,679	9/30/2020
2020 Q2	8/13/2020	80,846	0.7%	278,480	6/30/2020
2020 Q1	5/13/2020	41,187	0.4%	173,090	3/31/2020
2019 Q4	2/14/2020	25,240	0.2%	115,278	12/31/2019